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AbstrACt
Introduction Behavioural and cognitive behavioural 
programmes are commonly used to assist with weight 
management, but there is considerable scope to improve 
their effectiveness, particularly in the longer term. Third-
wave cognitive behaviour therapies (CBTs) have this 
potential and are increasingly used. This systematic 
review will assess the effect of third-wave CBTs for weight 
management on weight, psychological and physical health 
outcomes in adults with overweight or obesity.
Methods and analysis The systematic review will be 
reported according to the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses guidance. We 
will include studies of any third-wave CBTs focusing 
on weight loss or weight maintenance for adults with a 
body mass index (BMI) ≥25kg/m2. Eligible study designs 
will be randomised control trials, non-randomised 
trials, prospective cohort and case series. Outcomes 
of interest will be body weight/BMI, psychological 
and physical health, and adherence. We will search 
the following databases from inception to 16 January 
2018: MEDLINE, CINAHL, Embase, Cochrane database 
(CENTRAL), PsycINFO, AMED, ASSIA and Web of Science. 
The search strategy will be based on the concepts: (1) 
third-wave CBTs and (2) overweight, obesity or weight 
management. No restrictions will be applied. We will 
search reference lists of relevant reviews and included 
articles. Two independent reviewers will screen articles 
for eligibility using a two-stage process. Two independent 
reviewers will extract data, assess risk of bias using Risk 
of Bias 2.0, Risk of Bias in Non-randomised studies of 
Interventions or Risk of Bias in Non-randomised Studies of 
Exposures checklist and assess quality using the Grading 
of Recommendations Assessment, Development and 
Evaluation tool. A random-effects network meta-analysis 
of outcomes, and sub-group analyses and meta-regression 
will be conducted, where data permit. If not appropriate, a 
narrative synthesis will be undertaken.
Ethics and dissemination Ethical approval is not 
required as no primary data will be collected. The 
completed systematic review will be disseminated in a 
peer-reviewed journal, presented at conferences and 
used to inform the development of a weight management 
programme.
PrOsPErO registration number CRD42018088255.
IntrOduCtIOn 
Overweight and obesity is a major public 
health challenge, due to its high prevalence1 2 
and associations with reduced physical and 
psychological health,3–5 as well as nega-
tive social and economic consequences.6–8 
Supporting people with overweight and 
obesity to achieve and maintain a healthier 
weight is an international priority. Most treat-
ment approaches for overweight and obesity 
combine diet and physical activity advice with 
psychological support to make behavioural 
changes. Most commonly, this is a standalone 
treatment, although it is also an accompani-
ment to surgery or pharmacotherapy.9 
There are a number of behavioural 
programmes that are effective for weight 
management in the short term, but there is 
substantial room for improvement in reach 
and effectiveness, particularly in terms of long 
term outcomes.10–12 While many people are 
able to apply behavioural strategies in order 
to lose weight, it is hard to sustain these in the 
strengths and limitations of this study
 ► Different third-wave cognitive behaviour thera-
py  (CBT) modalities and delivery methods will be 
distinguished, enabling investigation into their com-
parative effectiveness.
 ► In addition to the direct treatment effects, indirect 
treatment effects will be analysed using a ran-
dom-effects network meta-analysis.
 ► A comprehensive search strategy will be used with a 
large number of databases searched, no limitations 
applied and all prospective study designs included.
 ► A description of the intervention content, duration 
and delivery mode will be provided.
 ► It is anticipated that many papers will not provide 
sufficient details on all variables of interest, and we 
will be reliant on communication with corresponding 
authors for additional information.
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face of obesogenic physical and social environments, the 
biological drive to maintain body weight and the habitual 
nature of key behaviours.
One way that the effectiveness of behavioural 
programmes might be improved is to identify new strat-
egies that target psychological processes associated with 
better long-term weight loss and weight loss maintenance. 
Key among these is sustained motivation and the healthy 
and adaptive self-regulation of eating behaviour and 
emotions.13–15 Third-wave cognitive behaviour therapies 
(CBTs) have been identified as a potentially useful treat-
ment to address these important factors.
third-wave Cbts
Third-wave CBTs have a number of core components that 
distinguish these approaches from first-wave behaviour 
therapy and second-wave CBT, specifically an emphasis 
on openness, awareness and action.16 Types of third-wave 
CBTs include dialectical behavioural therapy (DBT), 
schema therapy (ST), acceptance and commitment 
therapy (ACT), acceptance-based behavioural treat-
ment (ABBT), mindfulness-based cognitive behavioural 
treatment (MBCT) or compassion-focused therapy 
(CFT).16–18 These treatments have been associated with 
adaptive self-regulation and sustained motivation across 
a number of health domains, for example, in depression 
and addiction.19–21
There are a number of ways in which these treat-
ments could support successful weight management. 
For example, fostering non-judgemental awareness of 
thoughts, feelings and behaviour could enable people to 
reduce overeating and to limit the influence of internal 
and external cues. Encouraging patients to experience 
potentially aversive internal experiences (cravings, 
anxiety and behavioural fatigue) and to pursue behaviour 
that is congruent with their goals and values could 
support them in adhering to a weight management plan, 
even when weight loss has plateaued. Fostering a compas-
sionate attitude towards the self could help prevent 
discouragement following minor lapses. Mindfulness and 
acceptance-based therapies have also been associated 
with improvements in psychological outcomes related to 
long-term weight management, including self-regulation, 
dietary restraint, emotional eating, body satisfaction and 
mood.22–26
Evidence to date
Previous systematic reviews have investigated the effect of 
third-wave CBTs on weight management.22–28
Although these reviews have consistently reported 
improvements for obesity-related eating behaviours and 
psychological outcomes, results for weight loss have been 
mixed. Only three reviews of interventions in people 
with overweight and obesity included a meta-analysis of 
weight or body mass index (BMI) outcomes.22 25 26 Rogers 
et al’s25 meta-analysis of eight studies reported a small but 
significant reduction in BMI, and the 16 studies included 
in Carrière et al’s22 meta-analysis reported a significant 
moderate effect on weight loss. However, no significant 
effect was found for BMI in Ruffault et al’s26 meta-anal-
ysis of nine studies. These differences may be attributable 
to variation in inclusion criteria and methods across the 
reviews.
In addition to mixed findings, there are a number of 
methodological limitations that constrain conclusions on 
the effectiveness of third-wave CBT for weight manage-
ment. The majority of reviews used a small number of 
databases,24–27 lacked a comprehensive search strategy26 
and conducted their database searches during or prior 
to 2016,23 25–28 meaning that existing reviews will not have 
captured all relevant research. In addition, there has been 
an emphasis on mindfulness, with some reviews excluding 
other therapy types22 23 and others using the term ‘mind-
fulness’ to encompass a range of third-wave CBTs. There 
has been a general failure in reviews to distinguish between 
different types of third-wave CBT or different methods of 
delivery, and detail on intervention content, delivery mode 
and intensity is lacking. This causes difficulties in assessing 
the comparative effectiveness of different approaches and 
limits their potential to inform future studies. Further-
more, little is known regarding participant adherence and 
attrition as only Olson and Emery28 provided detail on 
this outcome. This would provide important insights into 
intervention fidelity and acceptability.
The present systematic review will provide a more 
comprehensive review of the range of third-wave CBTs 
that have been used for weight management. It will 
interrogate a large number of databases and include 
all prospective study designs, while acknowledging the 
strength of randomised controlled trials. Importantly, it 
will distinguish between different treatment modalities 
and delivery methods, by pulling both the direct head-to-
head comparisons reported in earlier studies and the indi-
rect and mixed effects within a random-effects network 
meta-analysis framework. Meta-regression methods will be 
applied to identify and/or adjust for potential source(s) 
of heterogeneity. While change in weight is the primary 
outcome, this review will also capture a range of physical 
and psychological health outcomes and will summarise 
data on intervention adherence. This review will provide 
important information with which to inform the devel-
opment and refinement of third-wave CBTs for weight 
management.
Objectives
We aim to evaluate the effectiveness of third-wave CBTs 
for weight management in adults with overweight or 
obesity.
Primary objective
 ► To evaluate the effectiveness of third-wave CBTs for 
weight loss and weight loss maintenance in adults with 
overweight and obesity.
Secondary objectives
 ► To evaluate the effect of third-wave CBTs for weight 
loss and weight loss maintenance on psychological 
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and physical health outcomes in adults with over-
weight and obesity.
 ► To provide a detailed description of the content, dura-
tion and delivery of interventions.
 ► To identify the intervention characteristics that are 
associated with better outcomes and adherence.
MEthOds And AnAlysIs
Eligibility criteria
Studies will be selected according to the criteria outlined 
below.
Study designs
We will include original research articles, theses and 
dissertations reporting randomised control trials (RCTs), 
non-RCTs, prospective cohort (PC) and case series 
studies that report an outcome measure pre-intervention 
and post-intervention. No restrictions will be placed on 
language, year of publication or publication status.
Participants
We will include studies of community-dwelling adult 
human participants (aged ≥18 years) with overweight or 
obesity (BMI ≥25 kg/m2). Participants must be seeking 
assistance with weight loss or weight loss maintenance. No 
further restrictions will be made on gender, age, recruit-
ment method or co-morbid conditions.
Interventions
Studies will be included if they evaluated a third-wave 
CBT for the purpose of weight loss or weight loss main-
tenance. In terms of defining third-wave CBTs, they must 
be described as using DBT, ST, ACT, ABBT, MBCT or 
CFT. As these approaches are sometimes delivered as 
part of a multicomponent intervention, no restriction 
will be placed on the proportion of the intervention 
using the technique, although this may be considered 
in secondary analyses. Interventions will be of any dura-
tion or delivery mode. There will be no restriction placed 
on who delivers the intervention. If multiple arms are 
included in a study, any arm that meets the inclusion 
criteria will be included in the review. We will exclude 
studies that do not state that weight management is an 
aim of the intervention.
Comparators
For the meta-analysis, we will include studies with no 
comparator, that is, single-arm pre-post studies with no 
control arms. We will also compare third-wave CBTs to (1) 
no intervention or minimal intervention, and (2) other 
behavioural programme(s), as reported in the studies.
Outcomes
The primary outcomes will be:
 ► Body weight.
 ► BMI.
The secondary outcomes will be:
 ► Stress.
 ► Anxiety.
 ► Depression.
 ► Meta-cognition.
 ► Eating attitudes
 ► Eating behaviours.
 ► Body satisfaction.
 ► Quality of life.
 ► Blood pressure.
 ► Lipids.
 ► Glycaemia.
 ► Adherence to treatment.
Timing
We will include studies that report one or more of the 
primary or secondary outcome measures pre-interven-
tion and post-intervention. We will exclude studies in 
which the follow-up measures are less than 3 months 
from baseline, because of the identified need to find new 
approaches to improve long-term weight loss and weight 
loss maintenance.
Setting
No laboratory based interventions will be included. All 
other settings are eligible for inclusion.
Language
There will be no language restrictions.
Information sources and search strategy
Electronic searches
We will search the following databases: CINAHL, 
MEDLINE, Embase, Cochrane database (CENTRAL), 
PsycINFO, AMED, ASSIA and Web of Science. No restric-
tions to the search strategies will be applied, and data-
bases will be searched from inception to 16 January 2018. 
For studies published in a non-English language, appro-
priate employees of the university will be contacted to 
request a translation.
To identify studies for inclusion in this review, detailed 
search strategies will be developed for each electronic 
database by ERL, who has previous experience conducting 
systematic reviews, with input from a medical librarian. 
Other members of the systematic review team will also 
be consulted to ensure appropriateness of terminology 
and that no terms have been overlooked. The search 
strategy will include a number of key word and subject 
heading searches relating to the concepts: (1) Third-wave 
CBTs AND (2) Overweight, obesity or weight manage-
ment. Searches in the other databases will be based on 
the MEDLINE search strategy (see online supplementary 
additional file), with modification when appropriate to 
take into consideration database-specific terms. Search 
terms for the third-wave CBTs concept will be based on a 
systematic review of third-wave CBTs for eating disorders 
by Linardon et al.18
Other search methods
To enhance literature saturation, we will manually search 
reference lists of all primary studies identified as eligible 
for inclusion in the review and previous relevant reviews. 
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Authors of abstracts that were identified in the database 
searches will be contacted to identify whether the study 
findings have been published elsewhere or accepted for 
publication. A bibliography of the included studies will 
be circulated to the systematic review team to ensure no 
other studies they are aware of are excluded.
study records
Data management and selection process
We will import results from the searches into a Micro-
soft Excel spreadsheet, and duplicates will be removed. 
We will screen the study titles and abstracts to eliminate 
articles that clearly do not meet the inclusion criteria. 
There will be an initial piloting of this screening with 
an identical 10% of articles independently screened by 
two researchers to ensure consistency. If a high degree of 
disagreement occurs, the inclusion and exclusion criteria 
of the studies will be clarified through discussion with 
a third reviewer. Once piloting is completed, all article 
titles and abstracts will be independently screened by two 
researchers. We will obtain full-text papers where titles 
and abstracts are deemed to be relevant or where eligi-
bility is unclear. The obtained full-text articles will then 
be independently screened by two researchers, and their 
eligibility will be discussed to gain consensus. Where 
necessary, we will seek additional information from study 
authors to resolve any questions about eligibility. Reasons 
for exclusion of articles at the full-text screening stage will 
be recorded. A third reviewer will resolve disagreements, 
if required. Reviewers will not be blinded to authors, 
institution or journal when screening articles. In the case 
of multiple articles pertaining to the same study, all arti-
cles will be included and then collated to make best use 
of the data. A Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA)29 flow chart will be 
presented showing the process of study selection.
Data collection process
For studies that fulfil the inclusion criteria, we will extract 
data from articles onto a data collection form. This form 
will be based on the Cochrane data extraction form,30 
the Consolidated Standards of Reporting Trials 2010 
statement31 and the Template for Intervention Descrip-
tion and Replication checklist.32 This will ensure that an 
appropriate breadth and depth of detail will be captured. 
The data extraction form will be piloted on three articles 
before it is finalised. Data will be independently extracted 
by two researchers, and any discrepancies will be resolved 
by a third reviewer. Data analysis will be conducted using 
statistical programme Stata V.14.2 (StataCorp. 2015, Stata 
Statistical Software: Release 14).
data items
Data to be extracted from the studies will include:
 ► General information (eg, study authors, publication 
year, country and source of funding).
 ► Study aim.
 ► Population description.
 ► Study characteristics (eg, study design, randomisa-
tion, blinding and allocation concealment).
 ► Participants (eg, age, sex, race/ethnicity, socioeco-
nomic status, diagnosed condition(s), recruitment 
methods, sample size and weight).
 ► Intervention characteristics (eg, therapy type/content, 
mode of delivery, group or individual delivery, dose 
of intervention, duration of session, setting, profes-
sion who delivered the intervention and theoretical 
framework).
 ► Comparator intervention characteristics (eg, therapy 
type/content, mode of delivery, group or individual 
delivery, dose of intervention, duration of session, 
setting, profession who delivered the intervention and 
theoretical framework).
 ► Outcomes (eg, outcome(s) studied, whether self-re-
ported or objectively measured, duration of follow-up, 
statistical analysis and intervention effect sizes).
 ► Adherence and attrition (eg, total number of partic-
ipants at baseline and at follow-up measurements, 
reasons for attrition, attendance and adherence to 
intervention).
If studies provide data for multiple follow-up time 
points, data will be extracted for all time points. If 
multiple arms are included in a study, data from any arm 
that meets the inclusion criteria will be extracted.
Due to the objective of this study to provide detailed 
descriptions of the content of the interventions, attempts 
will be made to contact the corresponding author of the 
study to retrieve further information not provided in the 
article or in related publications. Study authors will also 
be contacted if there are any uncertainties regarding the 
study or missing data. If there is no response, authors 
will receive two email reminders. Authors will be given 
a 2-month timeframe to reply to this request for further 
information.
Outcomes and prioritisation
The primary outcomes of interest are body weight and 
BMI as the aim of our review is to evaluate the effect 
of the third-wave CBTs on weight management. Body 
weight will be reported as kg. BMI will be defined as 
body weight (kg) divided by height (m) squared and 
will be reported as kg/m2. We will record whether these 
measurements have been objectively assessed or have 
been obtained through participant self-report or other 
means.
Secondary outcomes are stress, anxiety, depression, 
meta-cognition, eating attitudes, eating behaviours, 
body satisfaction, quality of life, blood pressure, lipids, 
glycaemia and adherence to the third-wave CBT.
Psychosocial outcomes that have been associated with 
successful weight management have been included in 
order to understand the potential of third-wave CBTs to 
target these potential determinants of longer term weight 
control. Data for these outcomes will be extracted as 
reported in the study. It will be noted if a validated instru-
ment has been used.
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For blood pressure, data for systolic and diastolic 
blood pressure will be extracted separately, and it will 
be reported using the unit mm Hg. For lipids, data will 
be extracted for total cholesterol, low-density lipopro-
teins and high-density lipoproteins (HDLs) and reported 
using the unit mmol/L. If the ratio of total cholesterol to 
HDL has been presented, if possible, this will converted 
into the separate outcomes for total cholesterol and 
HDL, or the study author will be contacted for raw data. 
Glycaemia may be reported as glycated haemoglobin 
(HbA1c; mmol/mol or %) or glucose (random, fasting or 
2 hours; mmol/L). These outcomes are important as they 
are closely associated with weight and are risk factors for 
a range of chronic diseases.
Information relevant to adherence to treatment will 
include number of sessions attended, length and number 
of times practising skills, use of resources and devia-
tions from intervention instructions. Any information 
regarding participant attrition/retention, reasons for 
attrition and attendance at sessions will also be collected. 
This is important as it will enable investigation into the 
effect of intensity of interventions on weight manage-
ment and also give insight into the acceptability of the 
intervention.
risk of bias of individual studies
Two researchers will independently assess the included 
studies for risk of bias. Any discrepancies will be discussed 
with a third reviewer to gain consensus. We will pilot this 
approach with three studies. Risk of bias will be assessed 
using the Risk of Bias 2.0 (RoB 2.0) tool,33 the Risk of 
Bias in Non-randomised studies of Interventions tool34 or 
Risk of Bias in Non-randomised Studies of Exposures.35 
Choice of tool will be dependent on the study design. Any 
other potential sources of risk of bias not covered by the 
tools will be noted. Reviewers will not be blinded to study 
authors, journal or institution. Results will be presented 
in a summary table.
Meta-biases
To assess for selective outcome reporting, if a study 
protocol is available, the outcomes reported in the 
protocol and the article will be compared. If not avail-
able, the methods and results section of the article will be 
compared to check for any inconsistencies.
data synthesis
Intervention comparisons: direct
Standard pairwise random-effects meta-analysis will be 
conducted where the homogeneity of data and inter-
vention permit, using Stata V.14.2. The head-to-head 
comparisons will be conducted on the outcome measures 
reported at specific time-points of follow-up (eg, 3 months, 
6 months and 12 months). Studies that have outcomes 
that fall between these time-points will be combined with 
the closest time-point. Mean differences (for continuous 
data) and OR (for categorical data) and their 95% CIs 
will be estimated and reported.
Intervention comparisons: indirect and mixed
Random-effects network meta-analysis will be conducted 
to estimate the indirect and mixed effects using the Stata 
suite of commands for network meta-analysis, along with 
commands for visualisation and reporting of results.
Sensitivity analyses
Sensitivity analysis will be conducted to see the potential 
impact on the effect estimates of different study designs 
(eg, RCTs and cohort studies) by restricting the analysis 
to specific study types and/or by excluding one study 
designs at a time.
In the case of studies with two or more eligible inter-
vention arms, dependent on the similarity of the interven-
tions, results may be combined or be split into different 
groups. If different measures have been used to assess 
the same outcome and are sufficiently similar, they may 
be pooled or harmonised. If the effect measures are 
reported in different scales, meta-analysis will use stan-
dardised mean differences (standardised by the baseline 
SD value).
Statistical heterogeneity
The statistical heterogeneity (the portion of the vari-
ability that cannot be attributed to random error) of the 
studies will be tested using the I² statistic along with its 
95% CI. Forest plots showing the overlap of the confi-
dence intervals will also be provided to enable visual 
inspection. For the network meta-analysis, we will also 
report a total I2 statistic and the heterogeneity variance 
parameter (τ2 ) estimated from the network meta-anal-
ysis models.
Analysis of subgroups or subsets
If sufficient data are available, subgroup analysis will 
compare:
 ► Type of intervention (eg, therapy type, duration, 
delivery and intensity).
 ► Comparator intervention (eg, minimal intervention 
or other behavioural intervention).
 ► Health condition of participants (eg, type 2 diabetes).
 ► Length of follow-up (eg, 3 months, 6 months and 12 
months).
 ► Study design (eg, RCT, quasi-RCTs, PC and case 
series).
 ► Study quality (eg, risk of bias).
If sufficient data on important covariates are reported 
in the studies, meta-regression techniques will be 
applied to identify and/or adjust for potential sources 
of heterogeneity, if applicable.
Narrative analysis
If meta-analysis is determined not to be appropriate 
due to substantial heterogeneity of studies and outcome 
measures that cannot be pooled, a narrative synthesis will 
be completed. This will be provided in the text and tables 
to summarise and explain the characteristics and findings 
of the studies.
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Missing data
It is anticipated that rates of attrition and missing data 
for outcome measurements may be relatively high and 
that studies will adopt a variety of methods for handling 
missing data, including using only complete cases, using 
all observed data, multiple imputation, baseline obser-
vation carried forward and last observation carried 
forward. The details of the missing data and data analysis 
approach will be described in the review. Our main anal-
yses will use whichever analysis is reported in the paper. 
Where multiple approaches are reported, preference will 
be given to multiple imputation and all observed data 
methods. We will conduct a sensitivity analysis to evaluate 
whether the approach to missing data impacts on the 
primary outcome.
Confidence in cumulative estimate
The quality of evidence will be assessed using the Grading 
of Recommendations Assessment, Development and 
Evaluation approach.36 This will be used to judge studies 
for any methodological flaws. This assessment is suitable 
due to our inclusion of non-RCTs, PCs and case series 
design studies. Other assessments more appropriate for 
RCT design studies may misjudge the quality of studies 
using these designs.
Patient and public involvement (PPI)
This study is part of a larger programme of research funded 
by a National Institute for Health Research Programme 
Grant for Applied Research. In the development of 
this research programme, we held a workshop with 22 
members of Fakenham Weight Management Service, who 
identified the need for support with long-term weight 
management and who felt that psychological therapies 
were particularly important. The research proposal was 
then reviewed by three members of Fakenham Weight 
Management Service and the University of Cambridge 
PPI Panel prior to submission, then reviewed by PPI 
representatives on the funding panel, and revised in light 
of feedback. A PPI representative (Mrs Jennifer Bostock) 
is a member of our investigator team for this research 
programme; we have two PPI representatives on our 
programme steering committee (Mr Graham Rhodes and 
Mrs Norma Scullion), and we have established a Patient 
User Group panel for the programme. Each of these PPI 
representatives will contribute to the interpretation and 
dissemination of findings from this review and the trans-
lation of these findings into a new weight loss mainte-
nance programme.
EthICs And dIssEMInAtIOn
The potential of third wave CBTs in weight management 
has been recently recognised, especially for long-term 
outcomes. However, evidence of their effectiveness on 
weight is mixed, and previous reviews have a number of 
limitations; our review will address these weaknesses.
Our review will distinguish between the different thera-
pies and delivery modes, enabling investigation into their 
comparative effectiveness. A detailed description of the 
intervention content, duration and delivery mode will be 
provided and where possible, meta-regression will be used 
to identify (and/or to adjust for) the source of heteroge-
neity across the studies. Besides direct treatment effects 
using standard random-effects pairwise meta-analysis, 
we will also estimate the indirect treatment effects using 
random-effects network meta-analysis. This will allow us 
to include data from a range of prospective studies, not 
only randomised controlled trials.
Ethical approval is not required as no primary data 
will be collected. This systematic review will follow the 
PRISMA checklist.29 It is planned that this systematic 
review will be published in a scientific journal, presented 
at relevant conferences and will be used in the develop-
ment of a new weight management programme to help 
adults with overweight and obesity to reduce weight 
regain following weight loss. The findings of this review 
will be of interest to health professionals working with 
adults with overweight or obesity, researchers involved 
in the development, evaluation and implementation of 
weight management interventions and policy makers and 
those responsible for commissioning weight manage-
ment services.
Acknowledgements The authors would like to thank the University of 
Cambridge School of Clinical Medicine librarian Eleanor Barker for assistance 
in developing the search strategy. We would like to thank the patient and 
public involvement representatives who contributed to the development of 
this research: Mrs Jennifer Bostock, Mr Graham Rhodes, Mrs Norma Scullion, 
the University of Cambridge PPI panel, and patients of Fakenham Weight 
Management Service. 
Contributors ALA, AJH and SJG conceived the study, participated in the study 
design, provided input on methods, participated in the development of the initial 
search strategy and contributed to the drafting of the manuscript. ERL participated 
in the study design, provided input on methods, developed the initial search 
strategy and was responsible for drafting the manuscript. NI provided input on 
methods, participated in the preparation of the initial manuscript draft and reviewed 
drafts. CAH contributed to the drafting of the manuscript and advising and recruiting 
patient and public involvement. All authors critically reviewed the manuscript and 
approved the final version submitted for publication. 
Funding This protocol presents independent research funded by the National 
Institute for Health Research (NIHR) under its Programme Grants for Applied 
Research Programme (Reference Number RP-PG-0216-20010). ALA and SJG are 
supported by the Medical Research Council (MC_UU_12015/4). SJG is an NIHR 
senior investigator. The University of Cambridge has received salary support in 
respect of SJG from the National Health Service in the East of England through the 
Clinical Academic Reserve. 
disclaimer The views expressed are those of the authors and not necessarily 
those of the NHS, the NIHR or the Department of Health. 
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
 o
n
 4 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023425 on 1 August 2018. Downloaded from 
7Lawlor ER, et al. BMJ Open 2018;8:e023425. doi:10.1136/bmjopen-2018-023425
Open access
rEFErEnCEs
 1. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and 
projections to 2030. Int J Obes 2008;32:1431–7.
 2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national 
prevalence of overweight and obesity in children and adults during 
1980-2013: a systematic analysis for the Global Burden of Disease 
Study 2013. Lancet 2014;384:766–81.
 3. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer 
attributable to high body-mass index in 2012: a population-based 
study. Lancet Oncol 2015;16:36–46.
 4. Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke 
and risk factors in 188 countries, during 1990-2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet Neurol 
2016;15:913–24.
 5. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, Obesity, and 
Depression. Arch Gen Psychiatry 2010;67:220–9.
 6. Goettler A, Grosse A, Sonntag D. Productivity loss due to overweight 
and obesity: a systematic review of indirect costs. BMJ Open 
2017;7:e014632.
 7. Wang YC, McPherson K, Marsh T, et al. Health and economic burden 
of the projected obesity trends in the USA and the UK. Lancet 
2011;378:815–25.
 8. Withrow D, Alter DA. The economic burden of obesity worldwide: 
a systematic review of the direct costs of obesity. Obes Rev 
2011;12:131–41.
 9. Obesity: identification, assessment and management, 2017.
 10. Hartmann-Boyce J, Johns DJ, Jebb SA, et al. Behavioural weight 
management programmes for adults assessed by trials conducted in 
everyday contexts: systematic review and meta-analysis. Obes Rev 
2014;15:920–32.
 11. Barte JC, ter Bogt NC, Bogers RP, et al. Maintenance of weight loss 
after lifestyle interventions for overweight and obesity, a systematic 
review. Obes Rev 2010;11:899–906.
 12. Dombrowski SU, Knittle K, Avenell A, et al. Long term maintenance 
of weight loss with non-surgical interventions in obese adults: 
systematic review and meta-analyses of randomised controlled trials. 
BMJ 2014;348:g2646.
 13. Teixeira PJ, Carraça EV, Marques MM, et al. Successful behavior 
change in obesity interventions in adults: a systematic review of self-
regulation mediators. BMC Med 2015;13:84.
 14. Ohsiek S, Williams M. Psychological factors influencing weight loss 
maintenance: an integrative literature review. J Am Acad Nurse Pract 
2011;23:592–601.
 15. Teixeira PJ, Silva MN, Coutinho SR, et al. Mediators of weight loss 
and weight loss maintenance in middle-aged women. Obesity 
2010;18:725–35.
 16. Hayes SC, Villatte M, Levin M, et al. Open, aware, and active: 
contextual approaches as an emerging trend in the behavioral and 
cognitive therapies. Annu Rev Clin Psychol 2011;7:141–68.
 17. Hayes SC. Acceptance and commitment therapy, relational frame 
theory, and the third wave of behavioral and cognitive therapies - 
republished article. Behav Ther 2016;47:869–85.
 18. Linardon J, Fairburn CG, Fitzsimmons-Craft EE, et al. The empirical 
status of the third-wave behaviour therapies for the treatment 
of eating disorders: a systematic review. Clin Psychol Rev 
2017;58:125–40.
 19. Williams JM, Kuyken W. Mindfulness-based cognitive therapy: a 
promising new approach to preventing depressive relapse. Br J 
Psychiatry 2012;200:359–60.
 20. Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of 
mindfulness-based relapse prevention, standard relapse prevention, 
and treatment as usual for substance use disorders: a randomized 
clinical trial. JAMA Psychiatry 2014;71:547–56.
 21. Öst LG. Efficacy of the third wave of behavioral therapies: 
a systematic review and meta-analysis. Behav Res Ther 
2008;46:296–321.
 22. Carrière K, Khoury B, Günak MM, et al. Mindfulness-based 
interventions for weight loss: a systematic review and meta-analysis. 
Obes Rev 2018;19:164–77.
 23. Katterman SN, Kleinman BM, Hood MM, et al. Mindfulness 
meditation as an intervention for binge eating, emotional eating, and 
weight loss: a systematic review. Eat Behav 2014;15:197–204.
 24. O'Reilly GA, Cook L, Spruijt-Metz D, et al. Mindfulness-based 
interventions for obesity-related eating behaviours: a literature 
review. Obes Rev 2014;15:453–61.
 25. Rogers JM, Ferrari M, Mosely K, et al. Mindfulness-based 
interventions for adults who are overweight or obese: a meta-
analysis of physical and psychological health outcomes. Obes Rev 
2017;18:51–67.
 26. Ruffault A, Czernichow S, Hagger MS, et al. The effects of 
mindfulness training on weight-loss and health-related behaviours in 
adults with overweight and obesity: a systematic review and meta-
analysis. Obes Res Clin Pract 2017;11:90–111.
 27. Lyzwinski LN, Caffery L, Bambling M, et al. A Systematic Review of 
Electronic Mindfulness-Based Therapeutic Interventions for Weight, 
Weight-Related Behaviors, and Psychological Stress. Telemed J E 
Health 2018;24.
 28. Olson KL, Emery CF. Mindfulness and weight loss: a systematic 
review. Psychosom Med 2015;77:59–67.
 29. Moher D, Liberati A, Tetzlaff J, et al. Systematic reviews and meta-
analyses: the PRISMA statement. Annu Intern Med 2009;151:264–9.
 30. The Cohrane Public Health Group. Cochrane public health group 
data extraction and assessment template, 2011:1–22.
 31. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: 
updated guidelines for reporting parallel group randomised trials. 
BMC Med 2010;8:18.
 32. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of 
interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014;348:g1687.
 33. Higgins JPT, Savović J, Page MJ, et al. Revised cochrane risk of bias 
tool for randomized trials, 2016..
 34. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for 
assessing risk of bias in non-randomised studies of interventions. 
BMJ 2016;355:i4919.
 35. Morgan R, Sterne J, Higgins J, et al. A new instrument to assess 
Risk of Bias in Non-randomised Studies of Exposures (ROBINS-E): 
Application to studies of environmental exposure. Abstracts of 
the Global Evidence Summit, Cape Town, South Africa. Cochrane 
Database of Systematic Reviews 2017.
 36. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging 
consensus on rating quality of evidence and strength of 
recommendations. BMJ 2008;336:924–6.
 o
n
 4 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023425 on 1 August 2018. Downloaded from 
